SCHEMBL5527468

SCHEMBL5527468

C=C(C)C(=O)OCCCCCCCCCCCC.C=C(C)C(=O)OCCOP(=O)([O-])OCC[N+](C)(C)C.C=C(CCCC[Si](C)(C)C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ESR1 P03372 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
CDC25A P30304 1/20 0.47
AGTR1 P30556 1/20 0.47
AKT1 P31749 1/20 0.47
ADRA1A P35348 1/20 0.47
KCNH2 Q12809 1/20 0.47
MAPT P10636 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
NR5A2 O00482 1/20 0.44
NR5A1 Q13285 1/20 0.44
RECQL P46063 1/20 0.44
ADRA1D P25100 1/20 0.43
PTAFR P25105 1/20 0.43
HTR1D P28221 1/20 0.43
HTR2C P28335 1/20 0.43
ADRA1B P35368 1/20 0.43
DRD3 P35462 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14990456 0.86 LMNA (0.64) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL3923049 0.86 LMNA (0.64) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL4299694 0.82 LMNA (0.52) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL368310 0.81 LMNA (0.56) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL15158309 0.78 LMNA (0.59) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL1260875 0.78 LMNA (0.60) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL2122717 0.78 LMNA (0.60) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL2117527 0.78 LMNA (0.60) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL2118062 0.78 LMNA (0.60) LMNAESR1ADORA3CDC25AAGTR1
SCHEMBL223046 0.78 LMNA (0.60) LMNAESR1ADORA3CDC25AAGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11969528-B2 Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2024-04-30 US disclosed
US-11660214-B2 Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2023-05-30 US disclosed
US-20210361449-A1 DRUG ELUTING STENT AND METHOD OF USE OF THE SAME FOR ENABLING RESTORATION OF FUNCTIONAL ENDOTHELIAL CELL LAYERS SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2021-11-25 US disclosed
US-11039942-B2 Drug eluting stent and method of use of the same for enabling restoration of functional endothelial cell layers SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2021-06-22 US disclosed
EP-3525722-A1 DRUG ELUTING STENT AND METHOD OF USE OF THE SAME FOR ENABLING RESTORATION OF FUNCTIONAL ENDOTHELIAL CELL LAYERS Sino Medical Sciences Technology Inc. (CN) 2019-08-21 EP disclosed
WO-2018113416-A1 DRUG ELUTING STENT AND METHOD OF USE OF THE SAME FOR ENABLING RESTORATION OF FUNCTIONAL ENDOTHELIAL CELL LAYERS SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2018-06-28 WO disclosed
US-20180042738-A1 DRUG ELUTING STENT AND METHOD OF USE OF THE SAME FOR ENABLING RESTORATION OF FUNCTIONAL ENDOTHELIAL CELL LAYERS SINO MEDICAL SCIENCES TECHNOLOGY INC. (CN) 2018-02-15 US disclosed
US-9884142-B2 Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating ALCHIMEDICS (FR) 2018-02-06 US disclosed
US-20140296967-A1 DRUG ELUTING STENT WITH A BIODEGRADABLE RELEASE LAYER ATTACHED WITH AN ELECTRO-GRAFTED PRIMER COATING ALCHIMEDICS (FR) 2014-10-02 US disclosed
US-20070288088-A1 Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating ALCHIMEDICS (FR) 2007-12-13 US disclosed